Juan Ramón Alaix

Biography

 Juan Ramón Alaix is Chief Executive Officer of Zoetis. In this role, he leads the world's leading animal health company with a singular focus on animal health medicines and vaccines, complemented by diagnostic products, genetic tests, biodevices and a range of services. In addition, he is a member of the Zoetis Board of Directors. Under his leadership, the company generated annual revenue of $4.9 billion in 2016 with approximately 9,000 employees worldwide. Mr. Alaix has 35 years’ experience of increasing responsibility in finance, sales and management, including 20 years in the pharmaceutical industry. Prior to Zoetis, he served as President of Pfizer Animal Health since 2006, where he was responsible for the overall strategic direction and financial performance of the company. Mr. Alaix joined Pfizer from Pharmacia in 2003 as regional president. In the 1990s, he served in general management with Rhône-Poulenc Rorer in Spain and Belgium before becoming country president of Spain for Pharmacia in 1998.

Research Interest

 Mr. Juan Ramón Alaix has been the Chief Executive Officer of Zoetis Inc. since July 2012. Mr. Alaix served as the President at Pfizer Animal Health Inc. at Microtek Int. Inc. since 2006, where he was responsible for the overall strategic direction and financial performance. He has over 35 years of experience of growing responsibility in finance, sales and management, including 15 years in the pharmaceutical industry. Mr. Alaix served as Regional President of Central/Southern Europe of Pfizer Global Pharmaceuticals since 2003. He joined Pfizer from Pharmacia in 2003. He served as the Market President of Spain at Pharmacia Corporation from 1998 until its acquisition by Pfizer in 2003. In the 1990s, he served in general management with Rhýne-Poulenc Rorer in Spain and Belgium. He has been a Director of Zoetis Inc. since July 2012. Mr. Alaix serves as the President and Director of the International Federation for Animal Health (IFAH) and the Spain U.S. Chamber of Commerce. Mr. Alaix received a graduate degree in Economics from the Universidad de Madrid